Clinical and research tests for C1269683 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Results: 1 to 19 of 19

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
RightMed Mental Health test OneOme, LLC United States	6	15	D Deletion/duplication analysis T Targeted variant analysis
Genomind Pharmacogenetic Report Genomind, Inc. Genomind, Inc United States	14	27	T Targeted variant analysis
GeneSight Psychotropic Assurex Health, Inc. United States	6	14	D Deletion/duplication analysis T Targeted variant analysis
nP.v3 Tempus AI - ATL Tempus AI United States	4	13	T Targeted variant analysis
GeneSight CYP2D6 Assurex Health, Inc. United States	4	1	D Deletion/duplication analysis T Targeted variant analysis
Major depressive disorder and accelerated response to antidepressant drug treatment, 608516 (FKBP5 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Major depressive disorder, response to citalopram therapy in, 608516 (HTR2A gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Seasonal affective disorder, susceptibility to, 608516 (HTR2A gene) (Sequence Analysis-All Coding Exons) (Prenatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Seasonal affective disorder, susceptibility to, 608516 (HTR2A gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Unipolar depression, susceptibility to, 608516 (TPH2 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
NeuroIDgenetix AltheaDx/Castle Biosciences United States	2	11	D Deletion/duplication analysis T Targeted variant analysis
Neurotransmitter Metabolism Deficiency NGS Panel Fulgent Genetics United States	85	101	D Deletion/duplication analysis C Sequence analysis of the entire coding region
TPH2 Single Gene Fulgent Genetics United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
HTR2A Single Gene Fulgent Genetics United States	5	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
FKBP5 Single Gene Fulgent Genetics United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Clinical Exome Fulgent Genetics United States	5128	4672	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Nuclear-Mito NGS Panel Fulgent Genetics United States	1103	676	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Serotonin Metabolism Deficiency NGS Panel Fulgent Genetics United States	12	17	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Intellectual Disability NGS Panel Fulgent Genetics United States	1058	554	D Deletion/duplication analysis C Sequence analysis of the entire coding region

Results: 1 to 19 of 19

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.